Integrating multimodal clinical data with a large model for prostate cancer diagnosis.
Where this comes from
- Record sourced from PubMed, PMID 42034911.
- Also identified by DOI 10.1038/s41746-026-02670-x.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Accurate prostate cancer (PCa) diagnosis remains difficult because of tumor heterogeneity and the challenge of integrating multimodal clinical information. We developed Prost-LM, a multimodal large language model that jointly embeds MRI-derived features, numerical PSA values, and free-text clinical reports into a unified semantic space to enable deep cross-modal reasoning. Trained and validated on a large multi-center cohort of 3940 patients, Prost-LM achieved strong diagnostic performance, with an internal validation AUC of 0.954 for distinguishing PCa from benign conditions, outperforming MRI-only models (AUC = 0.868, P < 0.001). For detecting clinically significant PCa (Gleason score ≥ 7), Prost-LM reached an AUC of 0.955. Additionally, the model provides interpretable diagnostic decisions to support clinical verification. These results suggest Prost-LM can improve automated PCa diagnosis and support precision oncology through multimodal AI.